Latorie S. Jones

FDA investigator

Appears on 21 documents from 2015 to 2024, most often at sites in Arkansas. Most often cites design and construction features (21 CFR 211.42).

21
Documents on file
5.3
Observations per 483
2015
First seen
2024
Most recent

What they cite most

From 111 observations

Activity by year

2015: 5, 2016: 5, 2017: 2, 2018: 3, 2023: 2, 2024: 4

Where

Arkansas 4 · Texas 4 · India 3 · China 2 · Florida 2 · North Carolina 2

Is Latorie S. Jones coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

21 documents, newest first
FirmOpen
483 SERUM INSTITUTE OF INDIA PRIVATE LIMITEDJul 2, 2024 · Pune, India
483 Sharp Sterile Manufacturing, LLCJun 12, 2024 · Lee, Massachusetts
483 GlaxoSmithKline BiologicalsMar 12, 2024 · Saint-Amand Les Eaux, France
483 Indivior Manufacturing LLCJan 18, 2024 · Raleigh, North Carolina
483 Biogen U.S. CorporationOct 17, 2023 · Morrisville, North Carolina
483 Dendreon Pharmaceuticals LLCAug 10, 2023 · Seal Beach, California
483 Form 483 · FEI 3007102377Dec 4, 2018 · Zapopan, Mexico

About this profile

What does Latorie S. Jones inspect?

Latorie S. Jones appears on 21 documents on file covering 19 sites, most often in Arkansas.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.192 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Latorie S. Jones is dated Jul 2, 2024.